Chatham Capital Group’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
18,163
-211
-1% -$14.3K 0.16% 123
2026
Q1
$1.38M Sell
18,374
-1,355
-7% -$111K 0.2% 109
2025
Q4
$1.54M Buy
19,729
+265
+1% +$21.5K 0.22% 107
2025
Q3
$1.65M Sell
19,464
-191
-1% -$15.3K 0.24% 103
2025
Q2
$1.54M Sell
19,655
-110
-0.6% -$8.11K 0.23% 103
2025
Q1
$1.43M Buy
19,765
+825
+4% +$69.2K 0.24% 103
2024
Q4
$1.68M Sell
18,940
-770
-4% -$68.6K 0.28% 97
2024
Q3
$1.67M Buy
19,710
+35
+0.2% +$3.11K 0.27% 98
2024
Q2
$1.82M Buy
19,675
+275
+1% +$27.8K 0.32% 92
2024
Q1
$2.19M Buy
19,400
+2,450
+14% +$245K 0.4% 76
2023
Q4
$1.58M Sell
16,950
-102
-0.6% -$8.98K 0.32% 87
2023
Q3
$1.56M Sell
17,052
-96
-0.6% -$10.3K 0.35% 85
2023
Q2
$2.08M Buy
17,148
+3,843
+29% +$414K 0.44% 75
2023
Q1
$1.3M Buy
13,305
+8
+0.1% +$763 0.29% 104
2022
Q4
$1.08M Hold
13,297
0.25% 110
2022
Q3
$1.01M Buy
13,297
+1,200
+10% +$115K 0.25% 106
2022
Q2
$1.32M Buy
12,097
+30
+0.2% +$3.19K 0.3% 94
2022
Q1
$1.2M Buy
12,067
+166
+1% +$15.8K 0.23% 104
2021
Q4
$1.14M Buy
11,901
+20
+0.2% +$2K 0.21% 109
2021
Q3
$1.31M Buy
11,881
+174
+1% +$19.8K 0.25% 93
2021
Q2
$1.36M Buy
11,707
+2
+0% +$230 0.26% 92
2021
Q1
$1.22M Buy
11,705
+512
+5% +$63.7K 0.25% 97
2020
Q4
$1.35M Hold
11,193
0.3% 87
2020
Q3
$972K Buy
11,193
+29
+0.3% +$2.5K 0.24% 93
2020
Q2
$905K Buy
+11,164
New +$814K 0.23% 95

Other funds holding USPH

Chatham Capital Group's USPH Position: Q2 2026 in Review

Chatham Capital Group reduced its US Physical Therapy (USPH) stake by 1.1% in Q2 2026, selling an estimated $14.3K and leaving 18,163 shares worth $1.25M. The position accounts for 0.16% of the portfolio, ranked #123.

Chatham Capital Group first reported a position in USPH in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.19M in Q1 2024. 218 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Chatham Capital Group held 18,163 shares of US Physical Therapy worth $1.25M as of Q2 2026.
  • Chatham Capital Group sold 211 US Physical Therapy shares in Q2 2026, an estimated $14.3K.
  • US Physical Therapy made up 0.16% of Chatham Capital Group's portfolio in Q2 2026, its #123 holding.
  • Chatham Capital Group first reported a position in US Physical Therapy in Q2 2020 and has held it in 25 quarters since.
  • Chatham Capital Group's US Physical Therapy position peaked at $2.19M in Q1 2024.
  • 218 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Chatham Capital Group's 13F filing for Q2 2026, filed 13 Jul 2026.